Literature DB >> 25827130

FUCCI sensors: powerful new tools for analysis of cell proliferation.

N Zielke1, B A Edgar1.   

Abstract

Visualizing the cell cycle behavior of individual cells within living organisms can facilitate the understanding of developmental processes such as pattern formation, morphogenesis, cell differentiation, growth, cell migration, and cell death. Fluorescence Ubiquitin Cell Cycle Indicator (FUCCI) technology offers an accurate, versatile, and universally applicable means of achieving this end. In recent years, the FUCCI system has been adapted to several model systems including flies, fish, mice, and plants, making this technology available to a wide range of researchers for studies of diverse biological problems. Moreover, a broad range of FUCCI-expressing cell lines originating from diverse cell types have been generated, hence enabling the design of advanced studies that combine in vivo experiments and cell-based methods such as high-content screening. Although only a short time has passed since its introduction, the FUCCI technology has already provided fundamental insight into how cells establish quiescence and how G1 phase length impacts the balance between pluripotency and stem cell differentiation. Further discoveries using the FUCCI technology are sure to come.
© 2015 The Authors. WIREs Developmental Biology published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25827130      PMCID: PMC6681141          DOI: 10.1002/wdev.189

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Dev Biol        ISSN: 1759-7684            Impact factor:   5.814


INTRODUCTION

In recent decades, intense research and numerous fundamental discoveries have led to a relatively detailed knowledge of the regulatory network that governs the eukaryotic cell cycle.1 Most of these groundbreaking studies were conducted in unicellular organisms or immortalized cultured cells that proliferate autonomously when supplied with sufficient nutrients and growth factors. But in most situations in animals and plants, whether a cell proliferates, remains dormant, or exits the cell cycle to differentiate depends largely on its interactions with neighboring cells and physiological signals from elsewhere in the organism. Thus to tackle general problems in development, regeneration, and the transformation of normal cells into tumor cells, it is essential to understand how cell proliferation is regulated by a cell's context. Analysis of proliferating cells in whole organisms has proven difficult because traditional cell cycle markers such as nucleotide analogs (BrdU, EdU), or replication proteins (PCNA, Ki‐67) rely on immunofluorescent detection, which requires sample fixation. Recently, a novel methodology was introduced that allows monitoring cell cycle phasing in living cells, named FUCCI (Fluorescent Ubiquitination‐based Cell Cycle Indicator).2 Since its introduction in 2008, the FUCCI technology has revolutionized the analysis of cell proliferation in vivo and thereby permitted a number of groundbreaking discoveries (Figure 1). The FUCCI system takes advantage of two components of the DNA replication control system of higher eukaryotes, the licensing factor Cdt1 and its inhibitor Geminin. Cdt1 and Geminin have opposing effects on DNA replication, their abundance oscillates during the cell cycle, in an inverse pattern.3 Cdt1 protein peaks in G1 phase just before the onset of DNA replication, and declines abruptly after the initiation of S phase.4, 5 In opposition, Geminin levels are high during S and G2 phase, but low during late mitosis and G1 phase.6 The reciprocal expression of Cdt1 and Geminin is affected by the sequential activation of the E3 ubiquitin ligases APC/CCdh1 and SCFSkp2. The APC/C ubiquitin ligase is active from mid‐mitosis throughout G1 and targets Geminin for degradation, whereas the SCFSkp2 ubiquitin ligase is active only during S and G2 phases and targets Cdt1 for degradation.3 Interestingly, SCFSkp2 is a substrate of APC/CCdh1, a condition that enforces their reciprocally timed activity.7, 8 The FUCCI system relies on pairs of fluorescent proteins fused to degrons derived from Cdt1 and Geminin. These fluorescent FUCCI ‘probes’ are destabilized by APC/C and SCFSkp2 during different phases of the cell cycle, and thereby allow the accurate visualization of living cells in either G1 or S/G2/M by virtue of which FUCCI probe they express (Figure 2(a)).2 It is important to note that although most FUCCI systems are based on dual probes, it is possible to determine the cell cycle stage with a single FUCCI probe. The use of both probes, however, produces more reliable results because the cell continuously alternates between green and red, permitting automatic detection and continuous tracking of migrating cells.
Figure 1

Timeline illustrating the invention of the different FUCCI variants and the key discoveries that have been made with them.

Figure 2

The FUCCI concept. (a) The original FUCCI sensors mark cells residing in G1 phase with red fluorescence, while cells in S/G2/M are labeled in green. During a short period at the G1/S transition, both probes are present and hence the cells appear yellow. (b) Domain structure of the human Geminin‐based S/G2/M sensors. DB, destruction box; NLS, nuclear localization signal; CC, coiled‐coil domain. (c) Domain structure of the human Cdt1‐based G1 sensor. PIP, PCNA interaction motif; Cy, Cy motif; CC, coiled‐coil domain. (d) Time plot illustrating the sequential degradation of the FUCCI probes. Nuclear mAG‐hGem1–110 or pan‐localized mAG‐hGem1–60 accumulates during S and G2 phase, but is targeted for degraded during late mitotis and G1 phase by the E3 ligase, APC/C. The nuclear mKO‐hCdt130–120 probe accumulates during G1 phase and is degraded during S and G2 phase by the SCFSkp2 complex. (e) Overview of the fluorescent proteins that produce functional FUCCI sensors.

Timeline illustrating the invention of the different FUCCI variants and the key discoveries that have been made with them. The FUCCI concept. (a) The original FUCCI sensors mark cells residing in G1 phase with red fluorescence, while cells in S/G2/M are labeled in green. During a short period at the G1/S transition, both probes are present and hence the cells appear yellow. (b) Domain structure of the human Geminin‐based S/G2/M sensors. DB, destruction box; NLS, nuclear localization signal; CC, coiled‐coil domain. (c) Domain structure of the human Cdt1‐based G1 sensor. PIP, PCNA interaction motif; Cy, Cy motif; CC, coiled‐coil domain. (d) Time plot illustrating the sequential degradation of the FUCCI probes. Nuclear mAG‐hGem1–110 or pan‐localized mAG‐hGem1–60 accumulates during S and G2 phase, but is targeted for degraded during late mitotis and G1 phase by the E3 ligase, APC/C. The nuclear mKO‐hCdt130–120 probe accumulates during G1 phase and is degraded during S and G2 phase by the SCFSkp2 complex. (e) Overview of the fluorescent proteins that produce functional FUCCI sensors. The first iteration of the G1 sensor included the complete human Cdt1 protein fused to a monomeric version of Kusabira Orange (mKO2).2 However, ectopic expression of this construct interfered with cell cycle progression. This prompted Sakaue‐Sawano and coworkers to engineer a chimeric protein that supports normal cell cycle progression but still oscillates normally. The human Cdt1 protein contains three functional domains (Figure 2(c)): the N‐terminal region harbors a PIP box, which is recognized by the S phase‐specific ubiquitin ligase CRL4Cdt2.9, 10 The PIP box is followed by another degron termed Cy motif, which is crucial for proteasomal targeting by the SCFSkp2 ubiquitin ligase.9, 10 The central part of Cdt1 mediates the interaction with Geminin, whereas the C‐terminal domain is crucial for the loading of minichromosome maintenance (MCM) proteins.4, 11, 12, 13, 14, 15 The authors generated various deletion constructs and discovered that an N‐terminal fragment of hCdt1 (hCdt130–120) is sufficient for degradation during S and G2 phase. This truncation eliminates the Geminin‐binding region but maintains the Cy motif (aa 68–70), which is critical for SCFSkp2‐mediated proteasomal degradation.10 The deletion of the PIP box appeared to be crucial for the generation of a functional G1 sensor,2 but in retrospect this is a surprising finding as FUCCI sensors in most other species are solely based on the PIP box motif. Another noteworthy observation is that this original G1 sensor is only functional in conjunction with mKO2 or mCherry, whereas fusions with the monomeric version of AzamiGreen (mAG), EGFP, or mRFP1 were constantly expressed throughout the cell cycle (Figure 2(e)).2, 16 The human Geminin protein, used for the S/G2/M sensor, also contains several conserved domains (Figure 2(b)): The N‐terminal portion of Geminin harbors a destruction (D) box (RRTLKVIQP) that is crucial for APC/C‐mediated degradation,6, 17 and the central portion contains a coiled‐coil domain that mediates Cdt1 binding.15, 18, 19 Nuclear targeting of Geminin relies on two clusters of Arg and Lys residues that are localized between the D box and the coiled‐coil domain.17, 20 Based on this information, Sakaue‐Sawano et al. engineered a fusion protein consisting of mKO2 and the N‐terminal region of hGem (mAG‐hGem1–110) that allows robust detection of S/G2/M phase. The original FUCCI probes where both localized in the nucleus, which has many advantages, but also some disadvantages. On the one hand, nuclear targeting facilitates the detection of the reporter probes; but on the other hand, it makes it nearly impossible to recognize cell types and differentiation states based on characteristic cell morphologies. To overcome this limitation, Sakaue‐Sawano and coworkers extended their engineering approach, which gave rise to an even shorter Geminin fragment (hGem1–60) that is evenly distributed throughout the cell because it lacks a KKAK motif that is crucial for effective nuclear localization.20, 21 It turned out to be impossible to create an evenly distributed Cdt1 fragment that accumulates specifically during G1 phase, but this is only a minor drawback because in combination with hGem1–60 the silhouette of a cell can be recognized through most of the cell cycle. In contrast to hCdt130–120, both hGem1–110 and hGem1–60 support normal cell cycle oscillations in combination with various fluorescent proteins such as mAG, mCyan, Venus, or mCherry (Figure 2(e)).16, 21, 22 The increased selection of flourochromes supports the design of complex experimental setups involving multiple fluorescent reporter constructs, enabling the researcher to correlate cell cycle progression with various cellular processes such as protein subcellular localization or signaling events.

FUCCI EXPRESSING MICE

A major advantage of genetically encoded biosensors is that they allow the generation of transgenic organisms that can be used in various experimental setups and thus provide valuable resources for the research community (Table 1). Therefore, the team of Atsushi Miyawaki has generated transgenic mice that express either mKO2‐hCdt130–120 or mAG‐hGem1–110 under control of the synthetic CAG promoter, which includes the cytomegalovirus (CMV) early enhancer element and promoter, the first exon and first intron of the chicken β‐actin gene, and the splice acceptor of the rabbit β‐globin gene.37 To obtain bona fide FUCCI mice, the lines CAG‐mKO2‐hCdt130–120 (#596) and CAG‐mAG‐hGem1–110 (#504) were crossbred and further characterized. FUCCI#596/#504 transgenic mice showed red or green fluorescence expression in many somatic cell types (Table 1). As a proof of principle, the expression pattern of the FUCCI probes was determined in the developing brain using live microscopy.2 In the developing cerebral cortex, certain neural progenitors exit the cell cycle and migrate beyond the ventricular zone, where they differentiate into neurons or, at later stages, into glial cells. Tracking of FUCCI‐expressing cells revealed that cells shift during migration from to G1 to S/G2/M phase, demonstrating that the FUCCI method is suited for the analysis of cell cycle oscillations in complex tissues. A recent study showed that FUCCI#596/#504 mice have strong expression in the heart, which led to the development of an ex vivo culturing system to analyze cardiomyocyte proliferation by live microscopy.38 This approach indicated that the duration of S/G2/M phases increases during development, implying a link between the cell cycle and cardiomyocyte differentiation. Although the FUCCI probes used in the FUCCI#596/#504 mice are broadly expressed, the probes are not detectable in hematopoietic organs like spleen and bone marrow. However, random integration of expression constructs results in multiple lines with variable characteristics and two other combinations of FUCCI probes, CAG‐mKO2‐hCdt130–120 (#639) and CAG‐mAG‐hGem1–110 (#492), and CAG‐mKO2‐hCdt130–120 (#610) and CAG‐mAG‐hGem1–110 (#474) support robust expression in spleen and bone marrow.22, 24, 25 The FUCCI#639/#492 mice have been used to identify quiescent (G1‐arrested) IgG1‐type memory B cells in the spleen and to visualize their proliferation (activation) upon secondary immunization.25
Table 1

Transgenic FUCCI Animals

Mice
NameFUCCI Probe(s)PromoterNotesReferences
Mouse (Mus musculus)
FUCCI‐S/G2/M#504mAG‐hGem1–110 CAGConstant expression in most tissues, except hematopoietic system 2 23
FUCCI‐S/G2/M#492mAG‐hGem1–110 CAGConstant expression in the spleen 24 25
FUCCI‐S/G2/M#474mAG‐hGem1–110 CAGConstant expression in the bone marrow, high‐level expression in B lymphoid cells 22 24
R26R‐Venus‐hGem1–110 Venus‐hGem1–110 Knock‐in in rosa26 locusConditional expression with Cre/LoxP system. Homozygous viable, no apparent defects 26
FUCCI‐G1#596mKO2‐hCdt130–120 CAGConstant expression in most tissues, except hematopoietic organ 2 27
FUCCI‐G1#639mKO2‐hCdt130–120 CAGConstant expression in the spleen 24 25
FUCCI‐G1#610mKO2‐hCdt130–120 CAGConstant expression in the bone marrow 22 24
R26R‐mCherry‐hCdt130–120 mCherry‐hCdt130–120 Knock‐in in rosa26 locusConditional expression with Cre/LoxP system. Homozygous viable, no apparent defects 26
R26P‐FUCCI 2mCherry‐hCdt130–120 and Venus‐hGem1–110 Rosa26 (R26P)Can only be maintained in a heterozygous state, robust expression in embryonic and extra‐embryonic tissues 26
R26‐FUCCI 2aRmCherry‐hCdt130–120‐T2A‐Venus‐hGem1–110 CAG, reverse knock‐in in rosa26 locusStrong ubiquitous expression at all examined time points including trunk, forelimbs lung, and kidney at E13. Homozygous viable 28
Zebrafish (Danio rerio)
CeycilmKO2‐zCdt11–190 and mAG‐zGem1–100 EF1αConstant expression during early development 29
Ceycil2mKO2‐zCdt11–190 and mAG‐zGem1–60 EF1αConstant expression during early development 29
Clmc2:zFUCCImCherry‐zCdt11–190 and Venus‐hGem1–110 Cardiac myosin light chain 2 (cmlc2)Specifically expressed in embryonic caridomyocytes 30
Ins:zFUCCImCherry‐zCdt11–190 and mAG‐zGem1–100 Insulin regulatory elementSpecifically expressed in pancreatic β‐cells 31 32
Dual FUCCICherry‐zCdt11–190 and Flag‐Cerulean‐zGem1–100 Ubiquitin (pUb)Constant expression during all developmental stages and in adult fish 33 34
Fruitfly (Drosophila melanogaster)
S/G2/M‐GreenmAG‐hGem1–110 UAStBipartite expression systems allows specific labeling of cells in S/G2 and M phases in almost every tissue 35
Fly‐FUCCIGFP‐dE2F11–230 and mRFP1‐dCycB1–266 Ubiquitin (pUb), UASt, UASp, QUASConstant expression in most cell types with pUb, bipartite expression systems allow specific expression almost every tissue 36
CFP‐dE2F11–230 and Venus‐dCycB1–266 UASt, UASp, QUASBipartite expression systems allow specific expression almost every tissue 36
GFP‐dE2F11–230 and mRFP1‐NLS‐dCycB1–266 Ubiquitin (pUb), UASt, UASp, QUASConstant expression in most cell types with pUb, bipartite expression systems allow specific expression almost every tissue, NlS‐CycB1–266 is not functional polyploid tissues 36
CFP‐dE2F11–230 and Venus‐NLS‐dCycB1–266 UASt, UASp, QUASBipartite expression systems allow specific expression almost every tissue, NlS‐CycB1–266 is not functional polyploid tissues 36
Transgenic FUCCI Animals A major drawback of the first generation of FUCCI mice is that the corresponding transgenes are localized on different chromosomes, which complicated the maintenance of the line. To overcome this problem, Abe et al. generated a new transgenic line, named R26pFUCCI 2, which expresses both FUCCI sensors bidirectionally from a single transgene.26 Besides easier maintenance, the new design has the advantage that it simplifies the crossing of the FUCCI sensors into diverse mutant backgrounds. Instead of mKO2 and mAG, the FUCCI 2 mice use mCherry‐hCdt130–120 and mVenus‐hGem1–110 (Figure 3(b)). These sensors produce better color contrast and can be spectrally separated from GFP.16 Another problem of the first generation FUCCI mice is that the probes are expressed at very low levels in certain tissues. This variability is likely caused by the random integration of the FUCCI probes such that the CAG promoter is inactive or only weakly active in several tissues.39, 40 To solve the latter problem, the CAG promoter was replaced by the ubiquitously active Rosa26 promoter (R26p).41 To avoid positional effects of the transgene integration site, the R26pFUCCI 2 construct was flanked by chicken hypersensitive site 4 (cHS4) insulator sequences.42, 43 cHS4 insulator sequences were also utilized to separate the bidirectionally expressed FUCCI probes. Although the R26pFUCCI 2 line can be maintained only in a heterozygous state, this line showed robust expression of the FUCCI probes in embryonic tissues such as blastomeres at early cleavage stages as well as in extra‐embryonic tissues. Consistent with an earlier study in cell culture,16 the mCherry‐hCdt130–120 signal is detectable throughout G1 phase, but diminishes upon entry into S phase. In contrast, the mVenus‐hGem1–110 signal is present during S and G2 phases, and disappears rapidly in late M phase. Because both mCherry‐hCdt130–120 and mVenus‐hGem1–110 are absent during late M phase, no fluorescence signal was detected during that period. Conversely, there was a short period at the transition from G1 to S phase during which the cells emitted both red and yellow fluorescence.
Figure 3

FUCCI‐expressing mice. (a) In R26P‐FUCCI 2 mice, G1 cells are constitutively labeled by red fluorescence, whereas cells in S and G2 phases are marked in yellow. (b) Diagram of the R26P‐FUCCI 2 expression construct. mCherry‐hCdt130–120 and mVenus‐hGem1–110 are bidirectionally expressed from the ubiquitous rosa26 promoter (R26p). Two copies of the cHSC4 insulator separate the individual components of the R26P‐FUCCI 2 construct. (c) R26R‐mCherry‐hCdt130–120 mice conditionally mark cells in G1 phase by red fluorescence. (d) R26R‐mVenus‐hGem1–110 mice conditionally label cells in S/G2 phase by yellow fluorescence. (e) Either mCherry‐hCdt130–120 or mVenus‐hGem1–110 was targeted to the rosa26 locus. To control the expressions of mCherry‐hCdt130–120 or mVenus‐hGem1–110 in time and space, a neo cassette (neomycin‐resistant gene expressed under the control of the PGK1 promoter) flanked by loxP sequences was placed in front of each probe. The neo cassette can be excised by Cre‐mediated loxP recombination, resulting in expression of the FUCCI probes in all Cre‐expressing cells. SA, adenovirus splice acceptor. (g) R26R‐FUCCI2aR mice conditionally mark cells in G1 phase by red fluorescence and cells S/G2 phase by yellow fluorescence. (f) The multicistron FUCCIa2R construct was inserted in reverse orientation into the Rosa26 locus. The targeting construct contains the CAG promotor, a stop cassette consisting of the neomycin resistance gene flanked by loxP sites, mCherry‐hCdt130–120 and mVenus‐hGem1–110. Both FUCCI probes are separated by a 2A auto‐cleavages site, which produces iso‐stoichiometric quantities of both FUCCI probes.

FUCCI‐expressing mice. (a) In R26PFUCCI 2 mice, G1 cells are constitutively labeled by red fluorescence, whereas cells in S and G2 phases are marked in yellow. (b) Diagram of the R26PFUCCI 2 expression construct. mCherry‐hCdt130–120 and mVenus‐hGem1–110 are bidirectionally expressed from the ubiquitous rosa26 promoter (R26p). Two copies of the cHSC4 insulator separate the individual components of the R26PFUCCI 2 construct. (c) R26R‐mCherry‐hCdt130–120 mice conditionally mark cells in G1 phase by red fluorescence. (d) R26R‐mVenus‐hGem1–110 mice conditionally label cells in S/G2 phase by yellow fluorescence. (e) Either mCherry‐hCdt130–120 or mVenus‐hGem1–110 was targeted to the rosa26 locus. To control the expressions of mCherry‐hCdt130–120 or mVenus‐hGem1–110 in time and space, a neo cassette (neomycin‐resistant gene expressed under the control of the PGK1 promoter) flanked by loxP sequences was placed in front of each probe. The neo cassette can be excised by Cre‐mediated loxP recombination, resulting in expression of the FUCCI probes in all Cre‐expressing cells. SA, adenovirus splice acceptor. (g) R26R‐FUCCI2aR mice conditionally mark cells in G1 phase by red fluorescence and cells S/G2 phase by yellow fluorescence. (f) The multicistron FUCCIa2R construct was inserted in reverse orientation into the Rosa26 locus. The targeting construct contains the CAG promotor, a stop cassette consisting of the neomycin resistance gene flanked by loxP sites, mCherry‐hCdt130–120 and mVenus‐hGem1–110. Both FUCCI probes are separated by a 2A auto‐cleavages site, which produces iso‐stoichiometric quantities of both FUCCI probes. As mentioned above, the first generation of FUCCI mice suffered from variable expression levels of the probes due to the positional effects of random transgenesis. To completely avoid artifacts resulting random integration, another set of FUCCI mice (Figure 3(c)–(e)) was generated in which the probes were integrated into the Rosa26 locus via gene targeting, named R26RFUCCI 2. The Rosa26 locus supports ubiquitous gene expression, and its disruption has no apparent side effects.44, 45, 46, 47 To support the tracing of cell cycle oscillation in a tissue‐ or cell type‐specific manner, either mCherry‐hCdt130–120 or mVenus‐hGem1–110 were combined with a loxP‐flanked stop cassette that can be removed by the expression of Cre recombinase.48 A large collection of mice strains expressing Cre recombinase under control of defined enhancer sequences now exists, to which R26RFUCCI 2 mice can be crossed, providing a means for tissue‐specific expression of the FUCCI sensors. Both R26R‐mCherry‐hCdt130–120 and R26R‐mVenus‐hGem1–110 mice are homozygous viable and exhibit no apparent defects. To characterize the R26RFUCCI 2 mice, both lines were crossed with the EIIa‐Cre line that is based on the adenovirus Ella promoter and targets the expression of the Cre recombinase to the early mouse embryo.49 Both sensors were readily detectable during early embryogenesis and displayed characteristic cell cycle oscillations. The brightness of R26R‐mVenus‐hGem1–110 was similar to the R26RFUCCI 2 mice, but the signal of mCherry was reduced to about a half. One drawback of the R26R lines is that, as only one FUCCI sensor is employed, the fluorescence signal is lost during half of the cell cycle. This complicates the tracking of individual cells, which can be ‘lost’ during their long dark phase. However, this problem can be overcome by combining the R26R mice with constitutive cellular markers such as H2B‐EGFP or H2B‐mCherry.48, 50 These shortcomings, however, have motivated the development of another new FUCCI line termed R26‐FUCCI 2aR, which enables conditional expression of both FUCCI probes.28 In the R26‐FUCCI 2aR line, mCherry‐hCdt130–120 and mVenus‐hGem1–110 as well as a Cre‐removable stop cassette have been targeted in reverse orientation to the rosa26 locus (Figure 3(g)). Instead of the endogenous promoter, the R26‐FUCCI 2aR design relies on the synthetic CAG promoter, which yields higher expression than the endogenous promoter. One key feature of the R26‐FUCCI 2aR design is that the two FUCCI probes are separated by a T2A sequence, which catalyzes the separation of the individual peptides by a co‐translational mechanism termed ribosome skipping.51 This design has the advantage that both probes are always expressed in the same ratio, which simplifies the detection of green–red transitions. Moreover, the streamlined design of the R26‐FUCCI2aR line facilitates the combination of the FUCCI sensors with mutant backgrounds or other transgenic lines. As a proof of principle, Mort et al. have analyzed the expression in the developing lung epithelium of FUCCI2aR mice, and discovered remarkable regional differences in cell cycle phasing.28 Actively branching regions were predominantly in S/G2/M phase, whereas the prospective bronchial regions were mostly comprised of cells residing in G1 phase.

FUCCI‐EXPRESSING CELL LINES

The FUCCI technology is widely applicable in cell biology and therefore it is not surprising that several FUCCI‐expressing cell lines have been developed (Table 2). The most obvious application of these cell lines is to use the FUCCI sensors as a means for determining whether a certain treatment alters the duration of specific cell cycle phases. For example, a recent study used FUCCI‐expressing human retinal pigment epithelial (RPE‐1) cells to demonstrate that depletion of a centrosomal protein (CEP164) decreases the overall length of the cell cycle, but prolongs S phase.69 CEP164 has been implicated in nephronophthisis, an autosomal recessive polycystic kidney disease that is caused by dysfunction of the primary cilia, and thus these data may provide a link between aberrant DNA replication and the pathogenesis of nephronophthisis. Another recent study used FUCCI‐expressing HeLa cells to demonstrate that chemical inhibition of atypical protein kinase C (aPKC) impedes cell proliferation by lengthening G1 and S phases.70 Further experiments revealed that aPKC impinges on the cyclin‐dependent kinase inhibitor (CKI) p27/Xic1, which is a major determinant of G1 length. Together with functional studies conducted in Xenopus embryos, these data provide a direct link between apical–basal polarity and cell cycle progression, which may explain why polarized neural stem cells prefer proliferation to differentiation.
Table 2

FUCCI‐Expressing Cell Lines

Cell LineDescriptionSpecies of OriginReferences
BJ‐hTertForeskin fibroblastsHuman 52 53
EndoC‐βH2Pancreatic β cellsHuman 54
hESC H9Embryonic stem cellsHuman 55
hESC WA09Embryonic stem cellsHuman 56
HeLaCervical cancer cellsHuman 2 16
HCT116Colon cancer cellsHuman 57, 58, 59, 60
MKM45Stomach adenocarcinoma cellsHuman 61
RPE‐1Retinal pigment epithelial cellsHuman 52 53, 62
B16Melanoma cellsMouse 63
D2A1Mammary cancer cellsMouse 64
L1210Lymphocytic leukemia cellsMouse 65
mESC CGR8Embryonic stem cellsMouse 66
mESC E14Embryonic stem cellsMouse 67
NIH 3T3Fibroblast cellsMouse 28 68
NMuMGNormal murine mammary gland cellsMouse 16
S2‐R+Derived from late embryos Drosophila 36
FUCCI‐Expressing Cell Lines The FUCCI sensors can also serve as an effective means for connecting cellular processes such as protein degradation or changes in subcellular localization to specific stages of the cell cycle. Santos et al. utilized the FUCCI sensors to determine the cell cycle stages at which nuclear targeting of CycB1 induces mitosis.71 Likewise, Son et al. utilized FUCCI‐expressing mouse lymphoblasts to measure the rate of cellular growth in each cell cycle stage.65 This analysis revealed a distinct change in the growth rate at the G1–S transition, implying that growth and cell cycle progression are interconnected. Moreover, FUCCI‐expressing non‐transformed, immortalized RPE‐1 cells were successfully used to study the impact of DNA damage on cell fate decisions. This work revealed that non‐transformed cells progressively lose the capacity to restore cell proliferation after DNA damage‐induced G2 arrest, forcing them to undergo senescence. G1 cells, by contrast, retained their ability to reenter the cell cycle after DNA damage.52 A parallel study demonstrated that different phosphatases mediate the reversal of checkpoint arrest in G1 or G2.53 Although WT p53‐induced phosphatase 1 (Wip1) is crucial for the recovery in G2‐arrested cells by antagonizing p53, it appears to be dispensable for the recovery of G1‐arrested cells. Further experiments revealed that phosphoprotein phosphatase 4 catalytic subunit (PP4) mediates cell cycle re‐entry after DNA damage in G1. PP4 dephosphorylates Krüppel‐associated box domain‐associated protein‐1 (Kap‐1), which in turn prevents the p53‐dependent transcriptional activation of p21. Finally, the FUCCI technology can be used for visual distinction between actively proliferating and quiescent cells. For instance, FUCCI‐expressing NMuMG cells were utilized to explore cell cycle dynamics during the epithelial‐mesenchyme transition (EMT).2 Treatment with transforming growth factor β (TGF‐β) induces EMT in normal murine mammary gland (NMuMG) cells,72 and FUCCI markers showed that during this transition the fraction of red mKO2‐hCdt130–120‐expressing G1/G0 cells increased and the fraction of green mAG‐hGem1–110‐expressing S/G2/M cells decreased.

FUCCI IN STEM CELL LINEAGES

The FUCCI technology has already proven to be an effective tool for delineating the connection between cell cycle phasing and stem cell differentiation (see also Box 1). A recent study took advantage of the fact that the length of the G1 phase in neuronal stem cells nearly doubles during differentiation to FACS‐isolate neuronal stem cells from heterologous populations based on their FUCCI signatures.67 Furthermore, they demonstrated that FUCCI‐derived cell cycle parameters could be utilized to isolate rare cells that have acquired an iPS cell‐like state, thereby increasing the efficiency of reprogramming. Likewise, Coronado et al. utilized the FUCCI method to fractionate mouse embryonic stem cells (mESCs) according to their cell cycle stage, and subsequently evaluated whether cell cycle phasing influences mESC differentiation.66 This approach revealed that G1 cells differentiate more efficiently than cells in S or G2 phase. A more recent study analyzed this phenomenon in more detail and showed that the cell fate choice of hESCs depends on the abundance cyclin D1‐3.55 By fractionating hESCs according to their FUCCI signatures, Pauklin and Vallier demonstrated that only in early G1 phase, when CycD1‐3 levels are low, Smad2/3 is allowed to enter the nucleus and promote endoderm differentiation. In contrast, in late G1 when CycD1‐3 levels are high, CycD1‐3/CDK4 phosphorylates Smad2/3, which prevents it from localizing to nucleus, thereby allowing neurectoderm specification. Finally the cell cycle signature of hematopoietic stem cells (HSCs) was analyzed in FUCCI#474/#610 mice.24 This approach revealed that most HSCs express mKO2‐hCdt130–120, which confirmed the generally accepted model that most HSCs in the bone marrow are in G1/G0 phase. Consistent with findings in other stem cell systems, the fraction of mAG‐hGem1–110‐positive cells increased upon differentiation of HSCs. Interestingly, Yo et al. observed that the red fluorescence intensity varied among HSCs, implying that the mKO2‐hCdt130–120–high cells reside longer in G1 phase than the mKO2‐hCdt130–120–low cells. Interestingly, FACS isolated mKO2‐hCdt130–120–high cells had superior performance in a competitive repopulation assay, indicating that mKO2‐hCdt130–120 can be used as an additional marker for the purification of HSCs. In summary, these findings demonstrate that the FUCCI reporters are extremely useful to correlate cell cycle parameters with stem cell differentiation and may allow the development of more robust differentiation protocols. The G1 phase is of particular importance for the balance between self‐renewal and differentiation in stem cell lineages. The cell cycle of embryonic or neuronal stem cells is characterized by an extremely short G1 phase that lengthens during differentiation.104 Remarkably, recent work suggests that lengthening of the G1 phase is a cause, rather than a consequence of differentiation. It is assumed that a short G1 phase may restrict the window during which differentiation cues can act, and thus maintain self‐renewal and pluripotency/multipotency. Consistent with this hypothesis, several studies have demonstrated that experimental lengthening of G1 phase by manipulating G1‐specific cyclin/Cdk complexes tips the scale toward differentiation, whereas experimental shortening of G1 phase keeps the cells in the pluripotent/multipotent stage.55, 66, 67, 105

FUCCI IN NON‐MAMMALIAN MODELS

As it supports live imaging, the FUCCI system is particularly well suited for studying cell cycle dynamics during development, which motivated the construction of a zebrafish‐specific FUCCI system (zFUCCI).29 This was first attempted by introducing human FUCCI probes into fish. Transgenic zebrafish expressing mAG‐hGem1–110 under control of the hspa8 promoter worked as expected, labeling S/G2/M cells with green fluorescence. However, the mKO2‐hCdt130–120 probe was constantly expressed through all cell cycle phases, suggesting that the SCFSkp2‐mediated mechanism of Cdt1 degradation is not conserved in lower vertebrates. This setback prompted Atsushi Miyawaki's team to clone the zebrafish orthologs of Cdt1 and Geminin and to optimize them using the same strategy used to develop the human FUCCI probes. These experiments showed that a longer fragment of zebrafish Cdt1 (zCdt11–190) fused to mKO2 produces a probe with robust oscillation of red fluorescence in cultivated fish cells (Figure 4(c)). Closer inspection of the sequence revealed that zCdt11–190 contains only a PIP box, but no Cy motif, suggesting that the S phase‐specific CRL4Cdt2 ubiquitin ligase, but not the SCF ubiquitin ligase, mediates the degradation of mKO2‐zCdt11–190. This pathway requires chromatin‐bound PCNA, which binds to the conserved PIP box (QXRVTDF) located in the N‐terminus of Cdt1.9, 73 The activation of the CLR4Cdt2 E3 ligase can occur only at replication forks, and consequently the activity of this complex is restricted to S phase.9, 10 The activity of the SCFSkp2 complex, by contrast, lasts from S through G2 phase.10 Notably, in the original human FUCCI system, the PIP box had to be eliminated to allow faithful oscillation of the hCdt1‐based G1 marker,2 suggesting that human Cdt1 might be an exception in the family of Cdt1 proteins. Similar to the original FUCCI system, deletion analysis yielded D‐box containing fragments of zebrafish Geminin (zGem1–100 or zGem1–60) that can be used for the visualization of cells in S/G2/M (Figure 4(b)).
Figure 4

(a) The zebrafish FUCCI systems labels cells residing in G1 phase by red fluorescence, whereas green fluorescence indicates cells in S or G2 phase. (b) Domain structure of zebrafish Cdt1 compared to human Cdt1. PIP, PCNA interaction motif; Cy, Cy motif; CC, coiled‐coil domain. (c) Comparison of the functional domains of zebrafish and human Geminin. DB, destruction box; NLS, nuclear localization signal; CC, coiled‐coil domain. (d) Time plot illustrating the sequential degradation of the zFUCCI probes. Nuclear mAG‐zGem1–100 or pan‐localized mAG‐zGem1–60 accumulates during S and G2 phase, but is targeted for proteolysis during late mitotic stages and G1 phase by APC/C. The nuclear mKO‐hCdt130–120 probe is rapidly destroyed upon initiation of DNA replication by the S‐phase‐specific E3 ligase CRL4Cdt2. (e) Schematic of the multicistronic dual FUCCI construct. Cerulian‐3x‐FLAG‐zGem1–100 and Cherry‐zCdt1–190 are expressed as a single polypeptide under the control of the zebrafish ubiquitin promoter. Both FUCCI probes are separated by a 2A sequence, which self‐cleaves upon expression.

(a) The zebrafish FUCCI systems labels cells residing in G1 phase by red fluorescence, whereas green fluorescence indicates cells in S or G2 phase. (b) Domain structure of zebrafish Cdt1 compared to human Cdt1. PIP, PCNA interaction motif; Cy, Cy motif; CC, coiled‐coil domain. (c) Comparison of the functional domains of zebrafish and human Geminin. DB, destruction box; NLS, nuclear localization signal; CC, coiled‐coil domain. (d) Time plot illustrating the sequential degradation of the zFUCCI probes. Nuclear mAG‐zGem1–100 or pan‐localized mAG‐zGem1–60 accumulates during S and G2 phase, but is targeted for proteolysis during late mitotic stages and G1 phase by APC/C. The nuclear mKO‐hCdt130–120 probe is rapidly destroyed upon initiation of DNA replication by the S‐phase‐specific E3 ligase CRL4Cdt2. (e) Schematic of the multicistronic dual FUCCI construct. Cerulian‐3x‐FLAG‐zGem1–100 and Cherry‐zCdt1–190 are expressed as a single polypeptide under the control of the zebrafish ubiquitin promoter. Both FUCCI probes are separated by a 2A sequence, which self‐cleaves upon expression. Three transgenic zebrafish strains were generated, which express either mKO2‐zCdt11–190, mAG‐zGem1–100, or mAG‐zGem1–60 under control of the Xenopus EF1α promoter74 and subsequently crossbred (Figure 4(d)). The combination of mKO2‐zCdt11–190 and mAG‐zGem1–100 was named Cecyil (cell cycle illuminated), while mKO2‐zCdt11–190 and mAG‐zGem1–60 was termed Cecyil2 (Table 1). Time‐lapse imaging of primary cells derived from Cecyil fish showed robust oscillation of the zFUCCI probes. As the activity of the CRL4Cdt2 complex is restricted to S phase, cells residing in G2 phase should in theory be positive for both zFUCCI probes and therefore appear yellow. However, time‐lapse analysis did not reveal any double‐positive cells, even at G1–S transitions where the mammalian FUCCI probes overlap. A likely explanation for this is that the oscillation of the zFUCCI probes has only been analyzed in relatively fast dividing cells with short G2 phases, which are too short to allow significant mKO2‐zCdt11–190 re‐accumulation. Despite of this limitation, the zFUCCI system was successfully used in subsequent experiments. These revealed that two waves of cell cycle transitions occur during notochord development, a remarkable detail that was not noticed before.29 The activity of the EF1α promoter diminishes at later developmental stages, thus restricting the use of the Ceycil lines to early development. To overcome this limitation, Mochizuki et al. replaced Azami Green in EF1α‐mAG‐zGem1–100 with the brighter mCherry.75 In combination with GFP‐tagged Histone A2,76 EF1α‐mCherry‐zGem1–100 allows the detection of G1, S2/G2, and M phase in the developing zebrafish lens. Analysis of cell proliferation revealed that the cells in the lens epithelium proliferate in a stereotypical pattern that resembles the germinative zone of mice and chickens.77, 78, 79 Bouldin et al. recently released an improved version of the zFUCCI system that, in contrast to the original design, expresses both probes from a single transgene.33, 34 This dual FUCCI construct is comprised of Flag‐Cerulean‐zGem1–100 followed by a viral 2A peptide and Cherry‐zCdt11–190 (Figure 4(e)). Instead of using the EF1α promoter,74 which is mostly limited to early embryonic development, the dual FUCCI system relies on the zebrafish ubiquitin promoter,80 which is expressed ubiquitously at all embryonic stages as well as in adult fish. The 2A peptide is an autocatalytic cleavage site,51 and thus the multicistronic dual FUCCI polypeptide gives rise to iso‐stoichiometric amounts of a cerulean‐based S/G2/M sensor, and a Cherry‐based sensor, which is detectable only during G1 phase. Bouldin et al. utilized the dual FUCCI lines to determine cell cycle phasing during zebrafish somitogenesis, and thereby found that posterior progenitor cells enter a prolonged G2 phase.33 This prolonged G2 is due to downregulation of the phosphatase Cdc25, which is rate limiting for the G2/M transition.81 Ectopic expression of Cdc25 drives ectopic cell divisions and disrupts somitogenesis, indicating that the prolonged G2 phase is critical for the coordination of cell proliferation and morphogenesis.33 The FUCCI technology was also introduced into the urchordate Ciona intestinalis (sea squirt) to follow cell cycle progression in the developing embryo by real‐time microscopy.82 For this purpose, red/green‐fluorescent FUCCI probes, based on hGem1–110 as well as a PIP box‐containing fragment of human Cdt1 (hCdt11–100), were expressed during embryogenesis using a ubiquitously active promoter. This approach revealed that proper formation of the neural tube also requires a prolonged G2 phase that is introduced by transcriptional downregulation of Cdc25. Misexpression of Cdc25 overrode the cell cycle delay and thereby impaired neural tube closure, further supporting the notion that cell division and morphogenetic movements are two mutually exclusive processes that cannot occur simultaneously. Altogether, this body of work demonstrates that the FUCCI technology is a valuable tool for the visualization of developmentally programmed cell cycle changes, and hence enables us to uncover differences and similarities in the mechanisms regulating cell proliferation and morphogenesis between organs and species (see also Box 2). Research with tissue culture cells has focused primarliy on the regulation of G1 phase and G1/S transitions, but it is becoming increasingly clear that controlling the length of G2 phase and G2/M transitions is crucial for the coordination of cell proliferation with morphogenesis during development.106 The embryonic development of many species such as Xenopus laevis or D. melanogaster involves cleavage stage cycles, which are very rapid because they lack Gap phases. After a certain number of divisions, the cell cycle slows down because the maternal stockpiles of cyclins and other cell cycle regulators have been exhausted. The lengthening of the cell cycle coincides with the midblastula transition (MBT), during which the embryo initiates gene transcription.107, 108, 109 The switch to zygotic gene expression causes remodeling of the cell cycle and acquisition of a G2 phase. The phosphatase Cdc25 is rate limiting for the progression from G2 phase to mitosis in Drosophila and Xenopus.81, 110 Deregulation of Cdc25 by mutation of its upstream regulator tribbles causes precocious mitotic divisions, interfering with morphogenetic movements during Drosophila gastrulation.111, 112, 113 The zebrafish model is not only an attractive system for the analysis of developmental processes, but it is also becoming increasingly important for whole organism screening. Thus, it is not surprising that the zFUCCI technology has been successfully utilized as a readout during chemical screens. For instance, a recent study expressed the zFUCCI probes (mCherry‐zCdt11–190 and Venus‐zGem1–100) under control of the heart‐specific clmc2 promoter,83 and used this to identify compounds that stimulate cardiomyocyte proliferation in regenerating hearts.30 Another recent study used the zebrafish insulin promoter to direct the expression of the zFUCCI probes (mKO2‐zCdt11–190 and mAG‐zGem1–100) to pancreatic β cells,31 and subsequently screened for enhancers of β‐cell regeneration.32

FUCCI IN

Because of its powerful genetic toolkit and easy maintenance, the vinegar fly Drosophila melanogaster is one of the most versatile research model organisms. The first attempt to introduce the FUCCI method into flies relied on the original FUCCI probes that contained degrons from human Geminin and Cdt1.2 However, as in zebrafish, only mAG‐hGem1–110, and not mKO2‐hCdt130–120, oscillated in proliferating Drosophila cells. As it faithfully marks Drosophila cells in S, G2, and Mitosis, oscillation of mAG‐hGem1–110 can be used as an indicator for ongoing cell proliferation, but due the lack of a second marker it is nearly impossible to derive reliable information about the duration of individual cell cycles.35, 84 To overcome this limitation, we recently constructed a fly‐specific FUCCI system (Fly‐FUCCI) that allows continuous tracking of cell cycle dynamics.36 Instead of a Geminin‐based probe, the Fly‐FUCCI system uses an N‐terminal fragment of cyclin B (dCycB1–266) fused either to mRFP1 or Venus, which labels cells in S, G2, and M phases (Figure 5(b)). This fragment contains a D‐box that confers APC/C‐dependent proteolysis, but lacks the Cyclin box required for Cdk activation, and thus does not affect cell cycle progression. The Cdt1‐based sensor used in vertebrates has been replaced by an N‐terminal fragment of Drosophila E2F1 (dE2F11–203) fused to GFP or CFP (Figure 5(c)). This fragment contains a PIP box degron that mediates S phase‐specific degradation by the CRL4Cdt2 ubiquitin E3 ligase, but it is unable to bind DNA or active gene transcription. Flow cytometry and live imaging demonstrated that the combined expression of both Fly‐FUCCI probes allows the distinction of G1, S, and G2 phases, thus enabling accurate tracking of cell cycle transitions.36 Cells in G1 phase exhibited high levels of GFP‐dE2F11–203, but were devoid of mRFP1‐dCycB1–266. Cells in S phase, in contrast, showed low levels of GFP‐dE2F11–203 and high levels of mRFP1‐dCycB1–266. Cells in G2 phase expressed both probes and therefore appeared yellow (Figure 5(a)). In contrast to the Geminin‐based probes, dCycB1–266 localizes predominantly to the cytoplasm, which improves the recognition of cell morphologies. However, the dE2F11–230‐based probes are exclusively found in the nucleus. Because this differential localization of the two probes hampers automated analysis of imaging data, we also introduced the nuclear localization signal (NLS) of SV40 large T antigen into dCycB1‐266.85 Fluorescence imaging and flow cytometry demonstrated that NLS‐dCycB1–266 is efficiently targeted to the nucleus and that nuclear targeting did not impair the functionality of the probe. Ubiquitously expressed FUCCI probes have only limited use for the analysis of proliferating cells in complex tissues such as the nervous system or stem cell‐based epithelia. Therefore, we generated a set transgenic flies expressing the Fly‐FUCCI sensors either under the UASt promotor86 or the weaker germline‐adapted UASp promoter,87 or the QUAS promoter of the Q‐system.88 The expression of these FUCCI reporters can be activated in specific cell populations by targeted expression of their respective transcriptional activators, Gal4 and Q‐factor (QF) (Figure 5(e)). Large collections of Gal4 ‘driver’ lines have been generated, which cover virtually every Drosophila cell type and hence the Fly‐FUCCI system can be used in a variety of experimental setups. Furthermore, the modular design facilitates the use of the Fly‐FUCCI system in combination with advanced genetic tools such as MARCM89 or the TARGET system.90
Figure 5

FUCCI in flies. (a) Fly‐FUCCI marks cells in G1 phase in green, cells in S phase are labeled in red, and cells in G2 phase express both markers and therefore appear yellow. (b) Domain structure of Drosophila E2F1. PIP, PCNA interaction motif; DNA, DNA binding motif; MB, marked box; TA, transactivation domain. (c) Schematic of Drosophila cyclin B. DB, destruction box; CB, cyclin box. (d) Time plot illustrating the sequential destruction of the Fly‐FUCCI probes. GFP‐E2F11–230 accumulates during G1 phase, but is rapidly destroyed during S phase by CRL4Cdt2‐mediated degradation. Levels of GFP‐E2F11–230 recover during G2 phase. mRFP1‐CycB1–266 degradation is mediated by APC/C and lasts from mid‐mitosis throughout G1 phase. Levels of mRFP1‐CycB1–266 increase in S phase and reach their maximum at the end of G2 phase. (e) Table describing the promoter/fluorochrome combinations of the currently available Fly‐FUCCI transgenes. (f) Schematic of the multicistronic Fly‐FUCCI construct that has been optimized for the use in Drosophila cell lines. T2A autocleavage sites separate both, the Fly‐FUCCI probes and the neomycin resistance gene, thereby allowing rapid selection of stable cell lines.

FUCCI in flies. (a) Fly‐FUCCI marks cells in G1 phase in green, cells in S phase are labeled in red, and cells in G2 phase express both markers and therefore appear yellow. (b) Domain structure of Drosophila E2F1. PIP, PCNA interaction motif; DNA, DNA binding motif; MB, marked box; TA, transactivation domain. (c) Schematic of Drosophila cyclin B. DB, destruction box; CB, cyclin box. (d) Time plot illustrating the sequential destruction of the Fly‐FUCCI probes. GFP‐E2F11–230 accumulates during G1 phase, but is rapidly destroyed during S phase by CRL4Cdt2‐mediated degradation. Levels of GFP‐E2F11–230 recover during G2 phase. mRFP1‐CycB1–266 degradation is mediated by APC/C and lasts from mid‐mitosis throughout G1 phase. Levels of mRFP1‐CycB1–266 increase in S phase and reach their maximum at the end of G2 phase. (e) Table describing the promoter/fluorochrome combinations of the currently available Fly‐FUCCI transgenes. (f) Schematic of the multicistronic Fly‐FUCCI construct that has been optimized for the use in Drosophila cell lines. T2A autocleavage sites separate both, the Fly‐FUCCI probes and the neomycin resistance gene, thereby allowing rapid selection of stable cell lines. As a proof of principle, we expressed the Fly‐FUCCI system in different cell types of the adult intestinal epithelium (midgut), which is maintained by intestinal stem cells (ISCs) that differentiate into two major types of progenitor cells, enterocytes (EC), and enteroendocrine (EE) cells.91 ISC‐specific expression of the Fly‐FUCCI probes indicated that, under normal conditions, ISCs are arrested in either G1 or G2 phase.36 However, upon enteric infection, the Fly‐FUCCI system indicated increased numbers of S and G2 cells, demonstrating that changes in Fly‐FUCCI signatures can used for the detection of actively proliferating ISCs. Although a flow cytometric analysis indicated a G1 DNA content, the EE cells exhibited high levels of both GFP‐dE2F11–230 and RFP‐dCycB1‐266, implying that both APC/C and CRL4Cdt2 are inactive in quiescent EEs.36 This is a remarkable finding, as it is generally believed that high APC/C activity is a characteristic feature of terminally differentiated cells. Because of the low maintenance costs and their amenability to RNAi, cultured insect cells are becoming increasingly important for cell biology, biochemical experiments, and high‐content screening. This prompted us to generate an optimized expression Fly‐FUCCI vector for Drosophila cell lines (Figure 5(f)).36 This multicistronic vector expresses both Fly‐FUCCI probes and the neomycin resistance gene as a single polypeptide. The coding regions of these three components are separated by T2A sequences, which auto‐cleave in Drosophila cells.92 This design ensures that the two Fly‐FUCCI probes are produced stoichiometrically and facilitates the selection of stable cell lines, as only cells expressing the constructs at high levels are allowed to survive.

FUCCI IN PLANTS

Because immunohistological detection is hampered by plant cell walls, genetically encoded cell cycle sensors could greatly advance the analysis cell proliferation in Arabidopsis thaliana and other plant species. However, the regulatory network that governs the plant cell cycle is very different from that of animals, and this complicates the transfer of the FUCCI methodology to plants. The most promising attempt to create a FUCCI‐like system in plants is the recently invented CYTRAP system.93 This cell cycle sensor is based on a C‐terminal fragment of Arabidopsis Cdt1 (aCdt1363–571), which is degraded at the end of G2 phase and has no impact on cell cycle progression. To restrict its expression to S and G2 phase, the sensor (aCdt1363–571‐RFP) was combined with the promoter of the histone H3.1‐type gene HISTONE THREE RELATED2 (HRT2). The combined expression of HRT2::aCdt1363–571‐RFP and the G2/M‐specific sensor CycB1::aCycB1‐GFP94 labels Arabidopsis cells from S through early G2 phase with red fluorescence and cells from late G2 to M phase with green fluorescence. Major drawbacks of the CYTRAP system are its inability to label G1 cells and to distinguish between S and G2 phase. In the future, these limitations will likely be overcome by tagging additional plant cell cycle proteins that have alternate expression profiles.

FUCCI IN NON‐CANONICAL AND ABERRANT CELL CYCLES

Endoreplication cycles or endocycles are a cell cycle variant that consists only of G and S phases and thereby lead to the formation of polyploid cells.95, 96 The increased DNA content allows a higher transcription capacity that can facilitate cellular growth, hence endocycles are often employed in cellular lineages that give rise to cells with increased metabolic output or secretory functions. A regulative network that includes phase‐shifted oscillations of APC/C and CRL4Cdt2 activities, analogous to those seen in mitotic cells, mediates the endocycles in Drosophila salivary glands.95, 96 The endocycles in the Drosophila salivary gland occur asynchronously and as a consequence result in expression of the Fly‐FUCCI probes in cells that are labeled by either green ub‐GFP‐E2F11–230 (G phase) or red ub‐mRFP1‐CycB1–266 (S phase).36 A striking example for the importance of endocycles for tissue regeneration is found in the EC of the adult Drosophila midgut. These cells execute several endocycles as part of their normal differentiation program and thereby attain DNA contents between 8C and 32C. EC‐specific expression of the Fly‐FUCCI probes revealed that terminally arrested ECs arrest with low CRL4Cdt2 and high APC/C activity,36 similar to many G0‐arrested mammalian cells. However, the level of the APC/C‐sensitive mRFP1‐CycB1–266 probe dramatically increased upon enteric infection with Pseudomonas entomophila, reflecting the periodic suppression of APC/C activity that occurs during endocycle S phases.95, 96 Consistently, endocycling ECs also exhibited periodic loss of the CRL4Cdt2‐sensitive GFP‐E2F11–230 probe during S phases, demonstrating that the Fly‐FUCCI system can faithfully distinguish endocycling from arrested ECs. Similarly, FUCCI#596/#504 mice were utilized to visualize endocycle oscillations in the trophoblast cell lineage.22 As in Drosophila, endocycling in the trophoblast cell lineage involves many of the cell cycle regulators found in mitotic cells including APC/C and SCFSkp2.95, 96 Live imaging of FUCCI‐expressing trophoblast giant cells revealed that both E3 ligases are sequentially activated during endocycling. However, endocycles are not the only road to polyploidy, and endomitosis is another non‐canonical cell cycle variant that leads to the formation of polyploid cells.95 Endomitotic cells such as megakaryocytes execute an abortive mitotic cell cycle that lacks an anaphase B as well as cytokinesis. The FUCCI#610/#474 mice showed good expression in the bone marrow and thus were used to visualize the cell cycle oscillations of megakaryocytes.22 This analysis revealed that cells with lower polyploidy (<16C) cycle faster than cells with high polyploidy (>16C). The FUCCI technology has also proven to be valuable as a tool for the detection of aberrant cell cycles. For instance, real‐time imaging revealed that treatment of FUCCI‐expressing NMuMG cells with the topoisomerase II inhibitor, Etoposide, results in a transient G2 arrest followed by mitosis‐independent oscillation of the FUCCI probes. Likewise, live imaging of FUCCI‐expressing MEFs demonstrated that persistent telomere dysfunction causes a prolonged G2 phase followed by endocycles.97 Because endocycling is a common mechanism for the formation of polyploid cells,95, 96 it was suggested that telomere dysfunction might represent a novel mechanism for the formation of aneuploid cancer cells. Another interesting application comes from a recent study aimed at elucidating the mechanism of p53 activation in drug‐induced tetraploid cells.62 To address this question, the team of David Pellman had to overcome the problem that tetraploid G1 cells have the same DNA content as diploid G2 cells, which makes it nearly impossible to separate both populations by standard DNA detection‐based flow cytometry. The solution was to combine FACS‐sorting with FUCCI markers. The fact that diploid G2 cells express mKO2‐hGem1–110, whereas tetraploid G1 cells express mAG‐hCdt130–120, allowed Pellman's group to FACS sort true tetraploid cells, which were then utilized for RNAi screening. In summary, these studies underscore the value of the FUCCI method for analyzing irregular cell cycles and may help us to eventually understand the connection between polyploidy and tumor formation.

PERSPECTIVE

In summary, the Fly‐FUCCI technology represents a widely applicable method for the analysis of cell cycle oscillations in living cells. The FUCCI method has been introduced in all major model systems except C. elegans to study a broad range of topics such as stem cell differentiation, the coordination of proliferation with morphogentic processes, tissue regeneration, T cell activation, system level analysis of cell cycle oscillations, and drug screening. Furthermore, we anticipate that the combination FUCCI sensors and flow cytometry will have widespread applications in the future. A disadvantage that all FUCCI sensors have in common is that they cannot precisely detect the transition from S to G2 phase. A simple solution for this problem could be to integrate an S phase marker such as PCNA‐GFP98 into the FUCCI system. Another drawback of the current generation FUCCI sensors is that they cannot discriminate between G0 and G1 phases. A recent study reported that a Venus‐tagged p27 mutant lacking the CDK inhibitory activity (mVenus‐p27K‐) can be used in combination with FUCCI probes to discriminate between cells in G0 and G1 phases during cell cycle re‐entry after serum stimulation.99 However, this combination of markers failed to detect G0 cells during early stages of cell cycle exit upon serum withdrawal, and the corresponding mice strains suffered from low expression levels in certain tissues. If these problems can be overcome in the future, this approach could be a significant improvement to the FUCCI technology. The recent work on mice and flies indicated that lineage‐restricted expression of the FUCCI sensors greatly enhances their utility for analyzing the coordination of cell proliferation and differentiation. Therefore, we believe that the FUCCI sensors for other model organisms (e.g., Zebrafish and Arabidopsis) should also be modified so that their expression can be controlled in space and time. The most promising approach to achieve this goal appears to be the use of binary expression such as the Gal4/UAS system. In zebrafish, the Gal4/UAS system was introduced some time ago,100 but only recently has the Gal4 activator been combined with the Tol2 transposable element,101 which enabled the generation of a large collection of fish lines that express Gal4 in specific cells, tissues, and organs.102 The Gal4/UAS method has recently been established in Arabidopsis.103 These advances pave the way for the development of conditional versions of zFUCCI and CYTRAP, respectively.
  45 in total

1.  Temporal remodeling of the cell cycle accompanies differentiation in the Drosophila germline.

Authors:  Taylor D Hinnant; Arturo A Alvarez; Elizabeth T Ables
Journal:  Dev Biol       Date:  2017-07-12       Impact factor: 3.582

2.  Accurate delineation of cell cycle phase transitions in living cells with PIP-FUCCI.

Authors:  Gavin D Grant; Katarzyna M Kedziora; Juanita C Limas; Jeanette Gowen Cook; Jeremy E Purvis
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

Review 3.  Solving the Polyploid Mystery in Health and Disease.

Authors:  K J Gjelsvik; R Besen-McNally; V P Losick
Journal:  Trends Genet       Date:  2018-11-21       Impact factor: 11.639

4.  Watching the Internal Clock of Cells while They Move and Divide.

Authors:  Barry D Hughes
Journal:  Biophys J       Date:  2018-03-13       Impact factor: 4.033

5.  Cell lineage and cell cycling analyses of the 4d micromere using live imaging in the marine annelid Platynereis dumerilii.

Authors:  B Duygu Özpolat; Mette Handberg-Thorsager; Michel Vervoort; Guillaume Balavoine
Journal:  Elife       Date:  2017-12-12       Impact factor: 8.140

Review 6.  Tumor Dormancy and Slow-Cycling Cancer Cells.

Authors:  John E Davis; Jason Kirk; Yibing Ji; Dean G Tang
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  Visualization of Hepatocellular Regeneration in Mice After Partial Hepatectomy.

Authors:  Yuanxin Chen; Toshiyuki Hata; Fatima Rehman; Lu Kang; Liu Yang; Betty Y S Kim; Justin H Nguyen
Journal:  J Surg Res       Date:  2018-11-26       Impact factor: 2.192

Review 8.  Adult Cardiomyocyte Cell Cycle Detour: Off-ramp to Quiescent Destinations.

Authors:  Kathleen M Broughton; Mark A Sussman
Journal:  Trends Endocrinol Metab       Date:  2019-06-28       Impact factor: 12.015

9.  Relish plays a dynamic role in the niche to modulate Drosophila blood progenitor homeostasis in development and infection.

Authors:  Parvathy Ramesh; Nidhi Sharma Dey; Aditya Kanwal; Sudip Mandal; Lolitika Mandal
Journal:  Elife       Date:  2021-07-22       Impact factor: 8.140

Review 10.  The frontier of live tissue imaging across space and time.

Authors:  Qiang Huang; Aliesha Garrett; Shree Bose; Stephanie Blocker; Anne C Rios; Hans Clevers; Xiling Shen
Journal:  Cell Stem Cell       Date:  2021-04-01       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.